window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 24, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Partnerships & Funding

  • Biotech,Clinical Trials,Drug discovery,Funding,Oncology,Partnerships & Funding,Pharmaceuticals and therapeutics,Research & Development,Technology and platforms

    Neomorph raises $100 million to advance NEO-811 Phase 1/2 cancer trial and molecular glue degrader pipeline

    Neomorph has closed a $100 million Series B financing to [...]

    April 18, 2026
  • CDMOs & Manufacturing,Drug Development,European biotech,Logistics and distribution,Oncology,Partnerships & Funding,Supply Chain & Logistics

    Oncodesign expands ARRONAX deal to secure astatine-211 supply for radiotherapy research

    Oncodesign Services has expanded its collaboration with French research institute [...]

    April 18, 2026
  • Drug discovery,Oncology,Partnerships & Funding,Pharmaceuticals and therapeutics,Precision medicine,Research & Development,Technology and platforms

    Regeneron enters radiopharmaceuticals through multi-programme collaboration with Telix in oncology expansion

    Regeneron Pharmaceuticals has entered the radiopharmaceuticals field through a multi-programme [...]

    April 18, 2026
  • Biomanufacturing,Cell & Gene Therapy,Drug Development,Manufacturing,Partnerships & Funding

    Virica and Fujifilm target AAV manufacturing bottleneck with enhancer collaboration

    Scaling production of adeno-associated virus vectors remains a key barrier [...]

    April 9, 2026
  • Clinical Development,Neurosciences,Partnerships & Funding,Research & Development

    SonoNeu exits stealth as part of $41.3M ARPA-H programme to advance sonogenetics

    SonoNeu has emerged from stealth as part of a $41.3m [...]

    April 7, 2026
  • Clinical Development,Neurosciences,Partnerships & Funding,Research & Development

    AC Immune amends Lilly collaboration on Tau small molecules for Alzheimer’s disease

    AC Immune has amended its collaboration agreement with Eli Lilly [...]

    April 7, 2026
  • Clinical Trials,Neurosciences,Partnerships & Funding,Research & Development

    City St George’s and Paradigm Biopharmaceuticals study osteoarthritis pain drug mechanism

    City St George’s, University of London has partnered with Paradigm [...]

    April 7, 2026
  • Cell & Gene Therapy,Hematology,Manufacturing,Partnerships & Funding,Rare Diseases,Research & Development,Technology and platforms

    UMass Chan, Caring Cross and Trenchant BioSystems form sickle cell gene therapy manufacturing alliance

    UMass Chan Medical School, Caring Cross and Trenchant BioSystems have [...]

    March 31, 2026
  • Drug discovery,Oncology,Partnerships & Funding,Research & Development,Startups and innovations,Technology and platforms

    Symeres and Ambagon partner on molecular glue research in colorectal cancer

    Symeres and Ambagon Therapeutics are collaborating to evaluate molecular glues [...]

    March 31, 2026
  • Artificial Intelligence,Drug discovery,Partnerships & Funding

    Insilico Medicine signs $2.75bn AI drug discovery deal with Eli Lilly

    Insilico Medicine has signed a drug discovery collaboration with Eli [...]

    March 31, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Neomorph raises $100 million to advance NEO-811 Phase 1/2 cancer trial and molecular glue degrader pipeline
    Categories: Biotech, Clinical Trials, Drug discovery, Funding, Oncology, Partnerships & Funding, Pharmaceuticals and therapeutics, Research & Development, Technology and platforms
  • NICE expands Lokelma access for hyperkalaemia after draft recommendation
    Categories: Cardiovascular diseases, Chronic diseases, Market Access & Commercialization, Pharmaceuticals and therapeutics, Regulatory Affairs
  • Oncodesign expands ARRONAX deal to secure astatine-211 supply for radiotherapy research
    Categories: CDMOs & Manufacturing, Drug Development, European biotech, Logistics and distribution, Oncology, Partnerships & Funding, Supply Chain & Logistics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top